🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "focused steps to deal with household expense issues" in the upcoming financial statement.

During an interview with media outlets, she noted that curbing price rises is a collective task of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the highest among the Group of Seven advanced economies this year and next.

Possible Energy Bill Interventions

It is understood the administration could take action to reduce utility costs, for example by cutting the current 5% rate of value-added tax charged on energy supplies.

An additional option is to lower some of the policy costs presently added to household expenses.

Fiscal Limitations and Expert Predictions

The administration will obtain the latest draft from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much space there is for such measures.

The expectation from most experts is that Reeves will have to announce higher taxes or expenditure reductions in order to fulfill her voluntary borrowing rules.

Previously on the same day, calculations suggested there was a £22bn gap for the chancellor to address, which is at the more modest range of projections.

"It is a collective job between the Bank of England and the administration to bear down further on some of the causes of inflation," Reeves informed the BBC in the US capital, at the annual meetings of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the attention has been on likely tax rises, the chancellor said the most recent information from the OBR had not altered her vow to campaign commitments not to increase tax levels on earnings tax, VAT or National Insurance.

She blamed an "uncertain world" with growing geopolitical and commercial concerns for the Budget revenue measures, probably to be directed on those "wealthiest."

Global Trade Tensions

Commenting on worries about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests invariably are paramount."

Last week's statement by Chinese authorities to increase trade restrictions on critical minerals and other materials that are essential for high-technology manufacturing led US President the US President to suggest an further 100% tariff on goods from China, increasing the prospect of an all-out commercial conflict between the two economic giants.

The American finance chief described the Chinese move "commercial pressure" and "a international production power grab."

Asked about considering the US offer to participate in its dispute with China, Reeves said she was "extremely troubled" by China's measures and urged the Chinese government "not to put up barriers and restrict access."

She said the action was "harmful for the global economy and causes further challenges."

"I believe there are areas where we must challenge Chinese policies, but there are also valuable chances to trade with Chinese markets, including financial services and other areas of the economic system. We've got to get that equilibrium correct."

The chancellor also affirmed she was working with G7 counterparts "on our own essential resources strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

Reeves also acknowledged that the cost the National Health Service spends on pharmaceuticals could rise as a result of current discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

A number of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or scrapping projects in the United Kingdom, with several blaming the insufficient payments they are getting.

Last month, the Science Minister said the price the health service pays for drugs would have to increase to halt firms and pharmaceutical investment leaving the UK.

Reeves informed media: "We have seen due to the payment system, that drug testing, recent pharmaceuticals have not been available in the United Kingdom in the way that they are in other EU nations."

"Our aim is to make sure that patients getting care from the NHS are able to receive the top critical treatments in the globe. And so we are examining all of that, and... seeking to obtain additional capital into Britain."